Diabetes and risk of tuberculosis relapse: Nationwide nested case-control study

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Lee, Pin Hui ^a,b   Lin, Hui Chen ^a   Huang, Angela Song En ^a   Wei, Sung Hsi ^a,c   Lai, Mei Shu ^b   Lin, Hsien Ho ^b  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BISBIGUANIDE DERIVATIVE; ETHAMBUTOL; HEMOGLOBIN A1C; INSULIN; ISONIAZID; MEGLITINIDE; PYRAZINAMIDE; RIFAMPICIN; SULFONYLUREA DERIVATIVE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOLOGY; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; RECURRENCE RISK; REGISTER; TAIWAN; DIABETES COMPLICATIONS; EPIDEMIOLOGY; MIDDLE AGED; RECURRENT DISEASE; RISK FACTOR; TUBERCULOSIS, PULMONARY;

ADULT; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REGISTRIES; RISK FACTORS; TAIWAN; TUBERCULOSIS, PULMONARY;

EID: 84899758178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092623     Document Type: Article

References (39)

1. WHO (2012) Global Tuberculosis report 2012. World Health Organisation.
2. Crofts JP, Andrews NJ, Barker RD, Delpech V, Abubakar I (2010) Risk factors for recurrent tuberculosis in England and Wales, 1998-2005. Thorax 65: 310-314.
3. WHO (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. World Health Organization.
4. Murray J, Sonnenberg P, Shearer SC, Godfrey-Faussett P (1999) Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med 159: 733-740. (Pubitemid 29137767)
5. Goldhaber-Fiebert JD, Jeon CY, Cohen T, Murray MB (2011) Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. Int J Epidemiol 40: 417-428.
6. Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5: e152.
7. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, et al. (2011) The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Medicine 9: 81.
8. Lo HY, Yang SL, Chou P, Chuang JH, Chiang CY (2011) Completeness and timeliness of tuberculosis notification in Taiwan. BMC Public Health 11: 915.
9. Taiwan Centers for Disease Control (2006) Treatment guidelines for tuberculosis, 2nd edition. Available: http://www.cdc.gov.tw/infectionreportinfo. aspx?treeid=075874dc882a5bfd&nowtreeid=8dba723ff186fac0&tid= BAB48CF8772C3B05. Accessed 2013 March 5.
10. World Health Organization (2009) Treatment of Tuberculosis: guidelines for national programmes. Geneva, Switzerland. World Health Organization.
11. Taiwan Bureau of National Health Insurance (2012) National Health Insurance in Taiwan: 2012-2013 Annual Report. Available: http://www.nhi.gov.tw/ English/webdata/webdata.aspx?menu=11&menu-id=290&webdata-id= 2974&WD-ID=290. Accessed 2013 March 5.
12. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, et al. (2011) Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 34: 1419-1423.
13. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
14. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321: 405-412. (Pubitemid 30609442)
15. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
16. Lo HY, Suo J, Chang HJ, Yang SL, Chou P (2011) Risk Factors Associated With Death in a 12-Month Cohort Analysis of Tuberculosis Patients: 12-Month Follow-up After Registration. Asia Pac J Public Health. Published online before print, December 23, 2011, doi:10.1177/1010539511429591
17. Panjabi R, Comstock GW, Golub JE (2007) Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis 11: 828-837. (Pubitemid 47227613)
18. Millet JP, Orcau A, de Olalla PG, Casals M, Rius C, et al. (2009) Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health 63: 799-804.
19. Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, et al. (2005) Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 9: 556-561. (Pubitemid 40646843)
20. Bloss E, Chan PC, Cheng NW, Wang KF, Yang SL, et al. (2012) Increasing directly observed therapy related to improved tuberculosis treatment outcomes in Taiwan. Int J Tuberc Lung Dis 16: 462-467.
21. Selassie A, Pozsik C, Wilson D, Ferguson P (2005) Why Pulmonary Tuberculosis Recurs: A Population-based Epidemiological Study. Annals of Epidemiology 15: 519-525. (Pubitemid 40982127)
22. Greenland S, Finkle WD (1995) A Critical Look at Methods for Handling Missing Covariates in Epidemiologic Regression Analyses. American Journal of Epidemiology 142: 1255-1264. (Pubitemid 26006424)
23. Jimenez-Corona ME, Cruz-Hervert LP, Garcia-Garcia L, Ferreyra-Reyes L, Delgado-Sanchez G, et al. (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68: 214-220.
24. Dooley KE, Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet Infectious Diseases 9: 737-746.
25. Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, et al. (2004) Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 38: 199-205. (Pubitemid 38113027)
26. Getahun H, Harrington M, O'Brien R, Nunn P (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369: 2042-2049. (Pubitemid 46908825)
27. Bang D, Andersen AB, Thomsen VO, Lillebaek T (2010) Recurrent tuberculosis in Denmark: relapse vs. re-infection. Int J Tuberc Lung Dis 14: 447-453.
28. Jasmer RM (2004) Recurrent Tuberculosis in the United States and Canada: Relapse or Reinfection? American Journal of Respiratory and Critical Care Medicine 170: 1360-1366.
29. Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, et al. (2008) Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 167: 1486-1494.
30. Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, et al. (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139: 57-64. (Pubitemid 40066129)
31. Martens GW, Arikan MC, Lee J, Ren F, Greiner D, et al. (2007) Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol 37: 518-524. (Pubitemid 350058182)
32. Vallerskog T, Martens GW, Kornfeld H (2010) Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol 184: 6275-6282.
33. Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff TH, et al. (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27: 97-103. (Pubitemid 351171510)
34. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, et al. (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14: 29-34. (Pubitemid 27019919)
35. Kenneth J Rothman (2008) Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins. 362 p.
36. American Diabetes Association (2013) Standards of medical care in diabetes - 2013. Diabetes Care 36 Suppl 1: S11-66.
37. Chang TJ, Jiang YD, Chang CH, Chung CH, Yu NC, et al. (2012) Accountability, utilization and providers for diabetes management in Taiwan, 2000-2009: an analysis of the National Health Insurance database. J Formos Med Assoc 111: 605-616.
38. World Health Organization (2011) Collaborative framework for care and control of tuberculosis and diabetes: World Health Organization.
39. Sullivan T, Ben Amor Y (2012) The Co-Management of Tuberculosis and Diabetes: Challenges and Opportunities in the Developing World. PLoS Medicine 9: e1001269.